Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: LCS16 vs. COC User Satisfaction and Tolerability Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed comparing LCS16 vs COC for user satisfaction and tolerability in contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COC
  • LCS16

Snippet

Sponsor: Bayer | Conditions: Contraception | Phase 3 | Status: COMPLETED